Testogel

Quick links to important sections

Testogel

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Testogel

Property Description
Active ingredient Testosterone
Form Transdermal Gel (Cutaneous Gel)
Pharmacological class Androgens (Hormone Replacement Therapy)
Common purpose To restore hormone levels
Origin Synthetic, yet chemically identical to the natural hormone

What Type of Medicine is Testogel and What is it Made Of?

Testogel is a specific brand of Prescription-only medicine (POM) developed and widely marketed, classified as Hormone replacement therapy (HRT), belonging to the pharmacological category of Androgens. The product is a single-ingredient drug where the sole active substance is the Endogenous steroid hormone, Testosterone. This compound is a Synthetic preparation that is structurally and chemically identical to the primary Androgen naturally produced in the male body. Testogel is formulated as a clear Transdermal gel, utilizing a Hydroalcoholic base (specifically including ethanol 96%) to facilitate efficient delivery of the hormone into the system. The use of this specific Hydroalcoholic gel formulation is clinically recognized for providing effective Systemic absorption when compared to early non-gel transdermal patches. Establishing the drug's composition and class confirms its specific role as a targeted physiological replacement, distinguishing it from non-hormonal, symptomatic treatments.


Testogel's Form and General Therapeutic Purpose

Testogel is a Topical preparation intended for Cutaneous application that achieves Systemic absorption of the active ingredient through the skin. This Transdermal gel route of administration is designed for the continuous delivery of Testosterone, which distinguishes it from intermittent forms such as periodic injections, offering a more stable absorption profile that many patients find preferable for daily use. Its general therapeutic purpose is to provide Testosterone replacement in adult males with documented deficiency. As a form of Hormone replacement therapy (HRT), the function of Testogel is to supply the essential Androgen to the body, aiming to restore circulating hormone concentrations to the normal physiological range through Controlled release. Maintaining stable circulating levels is a key goal of this replacement therapy. The ability to achieve stable Systemic absorption via the skin is foundational to its overall purpose of correcting the hormonal deficit.

Regulatory References

  1. Testosterone-containing medicines - EMA referral
  2. Male Hypogonadism - StatPearls - NCBI Bookshelf

What side effects are possible with Testogel?

Possible Side Effects and Safety Information

The safety profile of Testogel (testosterone gel) is formally documented in government regulatory materials, classifying potential adverse reactions by their frequency and the System-Organ Class (SOC) affected. This classification provides a structured view of the medicine's documented safety characteristics.


Frequency and System Classification

Adverse effects listed as Very Common (may affect more than 1 in 10 users) typically involve Skin and Subcutaneous Tissue Disorders, specifically application site reactions such as erythema (redness), acne, or dry skin.

Common adverse reactions (may affect 1 to 10 in 100 users) cover several systems, including the Reproductive System (e.g., prostate enlargement, gynaecomastia), the Blood and Lymphatic System (e.g., increases in haematocrit and red blood cell count), and General Disorders (e.g., oedema or fluid retention).


Serious Safety Considerations

The official labeling notes that testosterone therapy is associated with the risk of Venous Thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. The risk of Polycythaemia (abnormally high red blood cell count) is also documented, necessitating routine monitoring of haematocrit and haemoglobin levels. Use is restricted in individuals with known or suspected advanced prostate carcinoma.


Population and Topical Constraints

A key characteristic of the transdermal gel formulation is the constraint regarding potential testosterone transfer from the application site to women or children, which can lead to virilization in the exposed person. Specific safety notes also apply to older adults concerning the required monitoring for prostatic disorders, and to pre-pubertal males regarding the risk of accelerated bone maturation.

Overdose and Emergency Response

Overdose and when to seek help

The Testogel overdose profile is defined by the manifestation of excessive androgen exposure, which necessitates immediate medical evaluation. Documented clinical signs include irritability, nervousness, weight gain, and the occurrence of prolonged or frequent erections.

Upon recognizing these signs of excess, it is officially required to contact a physician who will determine if treatment discontinuation or a dosage adjustment is needed. Management of excess exposure relies on supportive and symptomatic treatment, as no specific antidote is documented in the regulatory information.

Urgent medical attention is necessary under specific circumstances. Patients with severe pre-existing cardiac, hepatic, or renal insufficiency are designated in regulatory documents as a high-risk population. If severe complications, such as oedema or congestive cardiac failure, are suspected in these patients, treatment must be stopped immediately.

An essential exposure risk involves the accidental transfer of the gel to non-users, such as children or women, potentially resulting in virilization. If a non-user shows signs of exposure (e.g., premature puberty or changes in body hair), immediate medical advice must be sought. In any case of suspected overdose or secondary exposure, the application site should be washed immediately to minimize further systemic absorption.

Therapeutic Uses of Testogel

What Testogel treats: main uses and benefits

Primary Indication

Testogel is a testosterone replacement therapy (TRT) used to treat adult men who have been diagnosed with a deficiency of testosterone, a condition known as male hypogonadism. This condition occurs when the body does not produce enough of this natural hormone, which is essential for the development and maintenance of male physical characteristics.

Therapeutic Goals

The primary purpose of the treatment is to restore testosterone levels to a physiological range. By normalizing hormone levels, the therapy aims to alleviate the clinical symptoms associated with testosterone deficiency.

Potential Benefits and Effects

When testosterone levels are restored, several physiological and psychological areas may show improvement:

  • Sexual Function: Restoration of hormone levels can help improve libido (sexual desire) and may assist with certain types of erectile dysfunction caused specifically by low testosterone.
  • Body Composition: Testosterone plays a role in regulating fat distribution and maintaining muscle mass. Treatment may help in increasing lean body mass and reducing body fat.
  • Bone Density: Adequate testosterone levels are necessary for maintaining bone mineral density. The therapy can help support bone strength and reduce the risk of thinning bones associated with hypogonadism.
  • Mood and Energy: Men with low testosterone often report fatigue, irritability, or a depressed mood. Normalizing these levels can lead to improvements in energy levels, concentration, and overall sense of well-being.
  • Secondary Sexual Characteristics: The treatment helps maintain masculine features, such as body hair distribution and voice depth.

Types of Hypogonadism Treated

Testogel is used to treat two forms of male hypogonadism:

  1. Primary Hypogonadism: When the deficiency originates from a problem in the testicles themselves.
  2. Hypogonadotropic Hypogonadism: When the deficiency is caused by a dysfunction in the pituitary gland or the hypothalamus, which are the parts of the brain that signal the body to produce testosterone.

Eligibility and Restrictions for Use

Testogel is intended exclusively for Adult Males who have a documented deficiency of endogenous testosterone, confirmed by both clinical features and multiple laboratory tests. Use is restricted solely to treating officially recognized male hypogonadism (Primary or Hypogonadotropic).


Contraindicated Populations

Official regulatory labeling establishes several absolute prohibitions. The medicine must not be used in men with known or suspected carcinoma of the prostate or carcinoma of the breast.

Testogel is also contraindicated in all women, especially those who are pregnant or breastfeeding, due to the risk of fetal harm and virilization. Children and women must also strictly avoid contact with the patient's application site due to the potential for secondary exposure.


Specific Eligibility Restrictions

Age Restrictions

Safety and efficacy have not been established in males under 18 years old or for the treatment of age-related hypogonadism in older men, limiting use to the approved adult male population.

Organ and Condition Restrictions

Patients with severe cardiac, renal (kidney), or hepatic (liver) insufficiency must use the medicine with caution, as it may cause fluid retention and edema, potentially leading to congestive heart failure. Treatment must be immediately discontinued if such severe complications arise.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes interactions with Testogel (testosterone) that are officially documented in regulatory labeling. Close monitoring and potential dose adjustments are required for the co-administration of the following substances.


Documented Pharmacodynamic Interactions

Interacting Product Category Regulatory Statement & Implication
Oral Anticoagulants Concomitant use with testosterone may increase the effect of the anticoagulant. This requires close and frequent monitoring of Prothrombin Time (PT) and International Normalized Ratio (INR) to prevent bleeding.
Corticosteroids and ACTH Simultaneous use may increase the risk of edema (fluid retention).

Clinical and Population-Specific Notes

Fluid Retention Risk: Caution is specifically advised when administering Testogel with corticosteroids or Adrenocorticotrophic Hormone (ACTH) to individuals with pre-existing cardiac, renal, or hepatic disease. These patients have an elevated risk for developing significant edema due to fluid retention.

Metabolic/Enzyme Interactions: The official labeling does not contain explicit warnings or requirements regarding interactions with specific cytochrome P450 (CYP) enzymes, drug transporters, food, alcohol, or herbal products. No strictly contraindicated drug-drug combinations are listed in the interaction section; all documented interactions require specific precautionary measures and monitoring.

Mechanism of Action

Testosterone, the active pharmaceutical ingredient in Testogel, is a lipophilic, small-molecule steroid hormone that permeates the stratum corneum and enters systemic circulation. It functions primarily as an agonist at the intracellular Androgen Receptor (AR), a ligand-activated transcription factor belonging to the nuclear receptor superfamily.

Following passive cellular diffusion, testosterone binds to the cytosolic AR, displacing heat shock proteins and inducing a conformational change. The activated testosterone-AR complex subsequently translocates to the nucleus and dimerizes. This dimer binds to specific DNA sequences known as Androgen Response Elements (AREs) located in the promoter regions of target genes. The binding event modulates gene transcription, increasing or decreasing the synthesis of specific messenger RNA (mRNA) transcripts. This genomic action alters cellular protein synthesis, driving long-term cellular differentiation and function in target tissues like muscle and bone. Non-genomic effects, mediated through membrane-associated AR or second messenger systems, also contribute to the overall signaling cascade. System-level physiological consequences arise from this widespread cellular signaling modification.

Dosage and Administration Information

How to use Testogel

Testogel is designed for cutaneous administration, involving the once-daily application of a hydroalcoholic gel to the skin to achieve systemic absorption of testosterone. The official route of use limits application strictly to the shoulders and/or upper arms; the gel must not be applied to other areas such as the genitals, chest, or abdomen.

Official Administration Guidelines

Feature Guideline
Route Cutaneous (Topical/Transdermal) use.
Dosing Schedule The usual starting regimen is 40.5 mg testosterone (two pump actuations) once daily. The dose can be adjusted based on blood level monitoring in increments of 20.25 mg up to a maximum of 81 mg daily.
Frequency & Timing Applied once daily at approximately the same time each day, preferably in the morning. If a dose is missed, the subsequent dose should be applied at the usual time.
Preparation The multi-dose pump requires priming before the first use (three full actuations must be discarded) to ensure subsequent dose accuracy.
Age-Group Rules The standard adult regimen is applicable for elderly men. Use is not established for the pediatric population (males under 18).

Procedural Constraints

The administration protocol includes specific procedural constraints to ensure proper dosing and prevent secondary drug transfer. After the metered dose is applied to clean, dry, intact skin, hands must be washed thoroughly with soap and water immediately. The application site must then be covered with clothing once the gel is dry, and patients are required to wait at least one hour before showering or bathing.

The overall use protocol establishes a structured, continuous treatment plan where the initial dose is followed by a required period for dose assessment, typically performed by measuring pre-dose morning testosterone levels around 14 to 28 days after initiation or dose change.

Recent Clinical Evidence

Clinical Evidence for Testogel (Testosterone Gel)

Testogel, a transdermal testosterone gel, is authorized for testosterone replacement therapy in adult men diagnosed with male hypogonadism. This condition must be confirmed by specific clinical signs and two separate biochemical tests demonstrating testosterone deficiency. Clinical trials for Testogel primarily focus on its ability to restore and maintain serum testosterone concentrations within the normal physiological range.

Pharmacokinetic Profile

Clinical studies indicate that once-daily application of the gel generally results in serum total testosterone levels reaching a steady state within the first 24 hours. These levels are typically maintained within the eugonadal range for the duration of the application. This profile is often described as providing more consistent testosterone levels compared to the peaks and troughs associated with some injectable testosterone preparations.

Observed Efficacy Outcomes

Controlled studies in hypogonadal men have shown that treatment with testosterone gel can lead to an increase in the percentage of subjects achieving testosterone concentrations within the target physiological range (e.g., 300–1000 ng/dL). Across various studies, maintaining these levels has been associated with:

  • Sexual Function: Reported improvements in measures of sexual desire (libido) and erectile function compared to baseline in some patient groups.
  • Body Composition: Observations include increases in lean body mass (LBM) and decreases in fat mass (FM) in symptomatic men with low or low-normal testosterone levels over periods of six months to one year.
  • Quality of Life: Improvement in certain health-related quality-of-life scores, including mood and physical symptoms of androgen deficiency, have been noted in treated subjects.

Safety and Long-Term Data

Regular monitoring of certain laboratory parameters is a standard part of long-term androgen therapy, including haemoglobin and haematocrit (to check for polycythaemia), prostate-specific antigen (PSA), and lipid profiles. While some studies suggest transdermal gels may be associated with a lower risk of polycythaemia compared to injectable modalities, the overall risk and long-term cardiovascular implications of testosterone replacement therapy remain an area of ongoing research and clinical discussion, particularly in older men or those with existing cardiovascular risk factors.

Key Studies & References

  1. Public Assessment Report Scientific discussion Testogel 40.5 mg, transdermal gel in sachet (testosterone) NL/H/3735/004 (Regulatory Document)
  2. FDA Label: Testosterone Gel 1.62% for topical use (DailyMed/FDA)

Frequently Asked Questions (FAQ)

Common questions about Testogel (FAQ)


Q: How long does it typically take to start feeling the effects of Testogel?

According to official product information, Testogel is designed to deliver a stable dose of testosterone. Clinical studies indicate that serum testosterone levels typically reach a stable concentration, known as steady-state, within the first 24 hours after starting daily application. The timeframe for individuals to perceive changes in associated symptoms may vary.


Q: What happens if I stop using Testogel suddenly?

Discontinuing the medication may cause the symptoms related to testosterone deficiency to return or reappear over time. Official guidance indicates that hormone replacement therapy cessation should be managed in consultation with a healthcare provider.


Q: Can Testogel cause hair loss or balding?

Hair loss (alopecia) and an increase in hair growth (hirsutism) are noted as uncommon side effects (meaning they may affect up to 1 in 100 users) that may occur with testosterone replacement therapy, according to official regulatory documents.


Q: Can using Testogel affect my cholesterol levels?

Official labeling states that regular monitoring of key laboratory parameters, including lipid profiles (which measure substances like cholesterol), is standard for patients receiving long-term androgen therapy.


Q: Is Testogel considered a steroid?

Yes, Testogel contains the active substance testosterone, which is classified as an endogenous steroid hormone. It is categorized as an Androgen within the pharmacological class of Hormone Replacement Therapy (HRT).


Q: What is the main difference between Testogel and other types of testosterone replacement like injections?

Testogel is a transdermal gel designed for continuous delivery of the hormone through the skin. This transdermal route is associated with a profile of circulating testosterone levels that is generally more consistent compared to the peaks and troughs of some injectable preparations.


Q: Does Testogel carry a risk of cardiovascular issues, according to regulators?

Official labeling indicates that testosterone products, including the gel formulation, have been associated with reports of venous thromboembolic events (VTE), such as deep vein thrombosis (DVT) and pulmonary embolism (PE). A general warning about the risk of VTE is included in the official product labeling.


Q: Can Testogel interact with over-the-counter pain relievers like ibuprofen?

Official documentation specifically warns of possible interactions with oral anticoagulants (blood thinners) and corticosteroids. While non-prescription pain relievers like ibuprofen are not explicitly named, official documents emphasize the importance of communicating with a healthcare provider about all medicines and products being taken.


Q: Is it normal to see an increase in red blood cell count while on Testogel?

Increases in haematocrit and red blood cell count are listed as a Common adverse reaction (affecting 1 to 10 in 100 users) in official documents. Routine monitoring of these blood levels is standard practice during long-term therapy.


Q: Can the effectiveness of Testogel be affected by very hot or cold weather?

Testogel is formulated with ethanol, meaning it is flammable until dry, requiring it to be kept away from heat sources during application. Additionally, official information indicates that washing the application site sooner than prescribed may reduce absorption, so allowing the site to dry completely before washing is described.


Q: Is Testogel the same as taking testosterone pills?

No, they are different routes of administration. Testogel is a transdermal gel applied to the skin for absorption, whereas testosterone pills are taken orally. Each route results in a distinct absorption and metabolism profile.


Q: Can Testogel make me feel more energetic?

Testogel is intended to restore testosterone levels to the normal range in men with documented deficiency. Clinical studies have noted improvements in quality of life scores and physical symptoms of androgen deficiency, which may include low energy or fatigue.


Q: Is Testogel an approved treatment in countries outside the U.S. and Europe?

Yes, Testogel is an approved and regulated medicine in many countries globally. Official regulatory documents for the product are publicly available from government drug agencies in territories such as Australia (TGA) and Canada (Health Canada), in addition to Europe (EMA) and the U.S. (FDA).


Q: Is Testogel used for delayed puberty in males?

No. Official documents state that the medicine is indicated only for testosterone replacement in adult men with hypogonadism. The safety and efficacy of the product have not been established for use in males under 18 years old.


Q: Does the gel have a strong smell?

Testogel utilizes a hydroalcoholic base, which includes ethanol, to help the hormone absorb through the skin. This component may result in a noticeable smell until the gel has completely dried on the application site.


Q: Is there a maximum time someone can be on Testogel therapy?

The medication is intended as a continuous treatment to help manage the symptoms of the condition. The overall duration of therapy is determined by a healthcare provider, and long-term use typically involves regular laboratory monitoring of blood levels and other safety parameters.


Q: Is it possible to be allergic to Testogel?

Official documents indicate that the medicine is contraindicated (should not be used) in patients with a known allergy or hypersensitivity to the active substance, testosterone, or any of the product's other ingredients.


Q: What research is available on Testogel's use in younger adult males?

The medication is approved for use in adult men with documented testosterone deficiency. Safety and efficacy have not been established for the use of the product in males under 18 years old, according to official labeling.

How should Testogel be stored and disposed of?

Storage and Disposal Requirements

Storage rules for Testogel (testosterone) vary by formulation. The multi-dose pump container must be stored below 30°C, while the sachet formulation generally does not require any special storage conditions. The product must be kept out of the sight and reach of children and in its original container.

Handling and Safety

Due to its ethanol content, the gel is flammable until dry, requiring the avoidance of sources of heat or naked flames during handling. Do not use the medicine past its expiry date.

Disposal Instructions

Official regulations require that unused or expired Testogel not be thrown away via wastewater or household waste. For environmental protection, the product must be returned to a pharmacist for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Testogel found in:

A-Z Index: